
AgenusDeveloper of a gene and cell therapy company focused on developing life changing treatments for serious diseases. The company's platform builds exclusive cutting-edge technologies and capabilities, based on a sector leading and proprietary single dose gene therapy platform LentiVector with which they design, develop and produce gene and cell based medicines for themselves and their partners in the areas of oncology, ophthalmology and CNS disorders.

Dejaremos saber a Oxford BioMedica que estos interesado en trabajar en la compania, manteniendo tu identidad personal anonima. Comparably le dara la oportunidad a Oxford BioMedica de contratarte. Cuando haya un puesto de trabajo que sea adecuado, haremos que se produzca la coincidencia.
Envíales una invitación para valorar la cultura de la empresa.